MEITAV INVESTMENT HOUSE LTD – UroGen Pharma Ltd. Transaction History
MEITAV INVESTMENT HOUSE LTD portfolio value:
$1.13M
portfolio value
MEITAV INVESTMENT HOUSE LTD quarter portfolio value change:
+1.59%
quarter
UroGen Pharma Ltd. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 12K | $8.32 | 136.83K | |
Q2 2022 | share | 0.00% | 0 shares | -71K | $8.19 | 136.83K | |
Q1 2022 | share | Decrease | -12.39% | -19.35K shares | -303K | $8.71 | 136.83K |
Q4 2021 | share | Increase | +23.38% | 29.59K shares | -634K | $9.9 | 156.18K |
Q3 2021 | share | Increase | +25.94% | 26.07K shares | 594K | $16.82 | 126.59K |
Q2 2021 | share | Increase | +58.85% | 37.23K shares | 302K | $15.27 | 100.51K |
Q1 2021 | share | Increase | 0.00% | 63.28K shares | 1.23M | $19.48 | 63.28K |
Q4 2020 | share | Decrease | -100.00% | -48.40K shares | -934K | $18.02 | 0 |
Q3 2020 | share | Increase | +11.91% | 5.15K shares | -194K | $19.29 | 48.40K |
Q2 2020 | share | Increase | +42.26% | 12.84K shares | 584K | $26.12 | 43.25K |
Q1 2020 | share | Decrease | -88.82% | -241.65K shares | -8.53M | $17.84 | 30.40K |
Q4 2019 | share | Increase | +9.44% | 23.47K shares | 2.77M | $33.37 | 272.06K |
Q3 2019 | share | Decrease | -56.04% | -316.95K shares | -13.99M | $23.83 | 248.59K |
Q2 2019 | share | Decrease | -0.05% | -300 shares | -593K | $35.94 | 565.54K |
Q1 2019 | share | Increase | +35.21% | 147.35K shares | 2.88M | $36.94 | 565.84K |
Q4 2018 | share | Decrease | -28.35% | -165.61K shares | -9.77M | $43.06 | 418.49K |
Q3 2018 | share | Increase | +14.68% | 74.74K shares | -2.16M | $47.23 | 584.10K |
Q2 2018 | share | Increase | +13.86% | 62.00K shares | 7.73M | $49.76 | 509.35K |
Q1 2018 | share | Increase | +8.35% | 34.47K shares | 6.86M | $49.69 | 447.35K |
Q4 2017 | share | Increase | 0.00% | 412.88K shares | 15.36M | $37.21 | 412.88K |